Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation

Gastroenterology

Volumn 124, Issue 2, 2003, Pages 392-400

  Wu, Shaoguang ^a   Morin, Patrice J ^b   Maouyo, Djik ^a   Sears, Cynthia L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ENTEROTOXIN; FRAGILYSIN; UVOMORULIN;

ACUTE DIARRHEA; ARTICLE; BACTERIUM ADHERENCE; BACTEROIDES FRAGILIS; CELL PROLIFERATION; CHEMICAL ANALYSIS; COLON CARCINOGENESIS; CONTROLLED STUDY; CYTOLOGY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; ONCOGENE C MYC; PRIORITY JOURNAL; RNA TRANSLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

EID: 0037309735     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50047     Document Type: Article

References (50)

1. Moore WEC, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974;27:961-979.
2. Redondo MC, Arbo MD, Grindlinger J, Snydman DR. Attributable mortality of bacteremia associated with the Bacteroides fragilis group. Clin Infect Dis 1995;20:1492-1496.
3. Sears CL. The toxins of Bacteroides fragilis. Toxicon 2001;39:1737-1746.
4. Obiso RJ Jr, Azghani AO, Wilkins TD. The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect Immun 1997;65:1431-1439.
5. Chambers FG, Koshy SS, Saidi RF, Clark DP, Moore RD, Sears CL. Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect Immun 1997;65:3561-3570.
6. Riegler M, Lotz M, Sears C, Pothoulakis C, Castagliuolo I, Wang CC, Sedivy R, Sogukoglu T, Cosentini E, Bischof G, Feil W, Teleky B, Hamilton G, LaMont JT, Wenzl E. Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro. Gut 1999;44:504-510.
7. Wells CL, Van De Westerlo EMA, Jechorek RP, Feltis BA, Wilkins TD, Erlandsen SL. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology 1996;110:1429-1437.
8. Myers LL, Firehammer BD, Shoop DS, Border MM. Bacteroides fragilis: a possible cause of acute diarrheal disease in newborn lambs. Infect Immun 1984;44:241-244.
9. Myers LL, Shoop DS, Firehammer BD, Border MM. Association of enterotoxigenic Bacteroides fragilis with diarrheal disease in calves. J Infect Dis 1985;152:1344-1347.
10. Obiso RJ Jr, Lyerly DM, Van Tassell RL, Wilkins TD. Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid secretion and intestinal damage in vivo. Infect Immun 1995;63:3820-3826.
11. Myers LL, Shoop DS, Stackhouse LL, Newman FS, Flaherty RJ, Letson GW, Sack RB. Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol 1987;25:2330-2333.
12. Myers LL, Shoop DS, Collins JE, Bradbury WC. Diarrheal disease caused by enterotoxigenic Bacteroides fragilis in infant rabbits. J Clin Microbiol 1989;27:2025-2030.
13. Koshy SS, Montrose MH, Sears CL. Human intestinal epithelial cells swell and demonstrate actin rearrangement in response to the metalloprotease toxin of Bacteroides fragilis. Infect Immun 1996;64:5022-5028.
14. Sears CL, Myers LL, Lazenby A, Van Tassell RL. Enterotoxigenic Bacteroides fragilis. Clin Infect Dis 1995;20(Suppl 2):S142-S148.
15. Sanfilippo L, Li CK, Seth R, Balwin TJ, Menozzi MG, Mahida YR. Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TGF-beta) by human colonic epithelial cells. Clin Exp Immunol 2000;119:456-463.
16. Kim JM, Oh YK, Kim YJ, Oh HB, Cho YJ. Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-kappa B plays a major role in the regulation of IL-8 expression. Clin Exp Immunol 2001;123:421-427.
17. Prindiville TP, Sheikh RA, Cohen SH, Tang YJ, Cantrell MC, Silva J Jr. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg Infect Dis 2000;6:171-174.
18. Wu S, Lim K-C, Huang J, Saidi RF, Sears CL. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci U S A 1998;95:14979-14984.
19. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-1851.
20. Morin PJ. Beta-catenin signaling and cancer. Bioessays 1999;21:1021-1030.
21. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin of APC. Science 1997;275:1787-1790.
22. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997;275:1784-1787.
23. Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER, Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ 1999;10:369-376.
24. Sasaki CY, Lin H, Morin PJ, Longo DL. Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin. Cancer Res 2000;60:7057-7065.
25. Yang SZ, Kohno N, Yokoyama A, Kondo K, Hamada H, Hiwada K. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines. Int J Oncol 2001;18:541-548.
26. van de Wetering M, Barker N, Harkes IC, van der Heyden M, Dijk NJ, Hollestelle A, Klijn JG, Clevers H, Schutte M. Mutant Ecadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res 2001;61:278-284.
27. 1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect Immun 1992;60:321-327.
28. Mundy LM, Sears CL. Detection of toxin production by Bacteroides fragilis: assay development and screening of extraintestinal clinical isolates. Clin Infect Dis 1996;23:269-276.
29. Gottardi CJ, Wong E, Gumbiner BM. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesionindependent manner. J Cell Biol 2001;153:1049-1060.
30. Van Tassell RL, Lyerly DM, Wilkins TD. Purification and characterization of an enterotoxin from Bacteroides fragilis. Infect Immun 1992;60:1343-1350.
31. Wu S, Dreyfus LA, Tzianabos AO, Hayashi C, Sears CL, Diversity of the metalloprotease toxin produced by enterotoxigenic Bacteroides fragilis. Infect Immun 2002;70:2463-2471.
32. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1989.
33. Furlong MT, Morin PJ. Rare activation of the TCF/beta-catenin pathway in ovarian cancer. Gynecol Oncol 2000;77:97-104.
34. Kolligs FT, Hu G, Dang CV, Fearon ER. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol 1999;19:5696-5706.
35. Neufeld KL, Zhang F, Cullen BR, White RL. APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep 2000;1:519-523.
36. Rosin-Arbesfeld R, Townsley F, Bienz M. The APC tumour suppressor has a nuclear export function. Nature 2000;406:1009-1012.
37. Zhang G, Weintraub A. Identification of Bacteroides fragilis by co-agglutination using a specific monoclonal antibody. Anaerobe 1997;3:295-300.
38. Saidi RF, Sears CL. Bacteroides fragilis toxin rapidly intoxicates human intestinal epithelial cells (HT29/Cl) in vitro. Infect Immun 1996;64:5029-5034.
39. Hardy RG, Meltzer SJ, Jankowski JA. ABC of colorectal cancer. Molecular basis for risk factors. BMJ 2000;321:886-889.
40. Peterson JW, Saini SS, Dickey WD, Klimpel GR, Bomalaski JS, Clark MA, Xu XJ, Chopra AK. Cholera toxin induces synthesis of phospholipase A2-activating protein. Infect Immun 1996;64:2137-2143.
41. Kagnoff MF, Eckmann L. Epithelial cells as sensors for microbial infection. J Clin Invest 1997;100:6-10.
42. Sears CL, Acheson DW. Enteric bacterial toxins. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. Philadelphia: Lippincott Williams & Wilkins, 2001.
43. Rozengurt E, Higgins T, Chanter N, Lax AJ, Staddon JM. Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc Natl Acad Sci U S A 1990;87:123-127.
44. Sellin JH, Umar S, Xiao J, Morris AP. Increased beta-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo. Cancer Res 2001;61:2899-2906.
45. Newman J, Kosaka T, Sheppard BJ, Fox JG, Schauer DB. Bacterial infection promotes colon tumorigenesis in ApcMin/+ mice. J Infect Dis 2001;184:227-230.
46. Go MF, Crowe SE. Virulence and pathogenicity of Helicobacter pylori. Gastroenterol Clin North Am 2000;29:649-670.
47. Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER. Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Genes Dev 2000;14:1319-1331.
48. Lara-Tejero M, Galan JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000;290:354-357.
49. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000;289:1560-1563.
50. Smits R, Ruiz P, Diaz-Cano S, Luz A, Jagmohan-Changur S, Breukel C, Birchmeier C, Birchmeier W, Fodde R. E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice. Gastroenterology 2000;119:1045-1053.